Lacosamide and Malignant neoplasm progression - a phase IV clinical study of FDA data

Summary:

Malignant neoplasm progression is reported as a side effect among people who take Lacosamide (lacosamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Keppra, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Lacosamide. It is created by eHealthMe based on reports of 16,542 people who have side effects when taking Lacosamide from the FDA, and is updated regularly.

What is Lacosamide?

Lacosamide has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 16,601 Lacosamide users. Check the latest studies of Lacosamide.

What is Malignant neoplasm progression?

Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,510 drugs and 1,635 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.

On Jul, 29, 2026

16,542 people reported to have side effects when taking Lacosamide.
Among them, 33 people (0.2%) have Malignant neoplasm progression.

Could Lacosamide cause Malignant neoplasm progression?

Among these 33 people:

How long have people been on Lacosamide when they have Malignant neoplasm progression? *

What is the gender of people who have Malignant neoplasm progression when taking Lacosamide? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Malignant neoplasm progression when taking Lacosamide? *

What are other drugs people take besides Lacosamide? *

What are other side effects people have besides Malignant neoplasm progression? *

Fatigue (feeling of tiredness): 8 people, 24.24%
Dizziness: 8 people, 24.24%
Fever: 7 people, 21.21%
Peripheral Motor Neuropathy (muscles in the body become progressively weaker over months to years): 7 people, 21.21%
Rashes (redness): 7 people, 21.21%
Xerosis (abnormal dryness of the skin or mucus membranes): 6 people, 18.18%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 6 people, 18.18%
Fall: 6 people, 18.18%
Erythema Migrans (lyme disease develop a red rash): 6 people, 18.18%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 6 people, 18.18%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 8 people, 24.24%
High Blood Pressure: 6 people, 18.18%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 15.15%
Prolactin-Producing Pituitary Tumor: 5 people, 15.15%
Delirium (wild excitement): 5 people, 15.15%
Hyperprolactinaemia (abnormally high levels of prolactin in the blood): 5 people, 15.15%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 12.12%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 9.09%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 3 people, 9.09%
Simple Partial Seizures (seizures which affect only a small region of the brain): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Lacosamide and have Malignant neoplasm progression?

- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lacosamide:

Lacosamide (16,601 reports)

Browse all side effects of Lacosamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,510 drugs)

Browse all the conditions that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,635 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Lacosamide) and Lacosamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.